epstein-barr-virus

Documents about epstein-barr-virus

• Hierarchical vision transformers for Epstein-Barr virus status and histological subtype prediction in Hodgkin lymphoma whole-slide images.#436966NCBI PubMed Central
• Development and validation of machine learning models for early diagnosis of hemophagocytic lymphohistiocytosis in pediatric Epstein-Barr virus infection.#630921NCBI PubMed Central
• Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT#835870ClinicalTrials.gov
• Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics.#334720NCBI PubMed Central
• A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma#863377ClinicalTrials.gov
• CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c#146510bioRxiv / medRxiv
• Epstein-Barr Virus (EBV) SM Protein Induces and Recruits Cellular Sp110b to Stabilize mRNAs and Enhance EBV Lytic Gene Expression#643577Harvard DASH
• A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases#267993ClinicalTrials.gov
• Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation#279492ClinicalTrials.gov
• Nippostrongylus brasiliensis and herpes simplex virus-2 co-infections: Impact on female genital tract microRNA and immune profiles, and potential role in cervical carcinogenesis.#197563ResearchSpace
• The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.#457508NCBI PubMed Central
• Chronic Presence of Epstein Barr Virus in Epithelial Cells From Gingiva is Associated With Periodontitis#877214ClinicalTrials.gov
• Playing both sides – Epstein-Barr Virus accumulates select cellular transcripts to counter virus-mediated host shut-off in lytic cells#172206PLOS
• Donor-Derived Viral Specific T-cells (VSTs)#842309ClinicalTrials.gov
• Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer#28333ClinicalTrials.gov
• EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)#839658ClinicalTrials.gov
• EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV/AIDS#649291University of Pretoria Repository
• Extracellular vesicles from wild-type Epstein–Barr virus–transformed B-cells export host DNA and the viral lncRNA EBER1#149878Unpaywall
• Environmental Risk Factors in Multiple Sclerosis Development: Epidemiological Study of EBV Infection and Vitamin D Deficiency in RIS Patients#846229ClinicalTrials.gov
• An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas#1009744ClinicalTrials.gov
• Integrated Bulk and Single-Cell Transcriptomic Analyses Identify a Five-Gene Signature Associated With Prognosis and the Tumor Microenvironment in Epstein-Barr Virus-Associated Gastric Cancer.#621046NCBI PubMed Central
• DMS-informed secondary structure modeling of Epstein–Barr Virus LMP-1 pre-mRNA defines novel elements spanning introns#335924PLOS
• Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease#401988DataCite
• Magnesium Supplementation in People With XMEN Syndrome#917586ClinicalTrials.gov
• Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas#801057ClinicalTrials.gov
• CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c#149877Unpaywall
• Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China#842312ClinicalTrials.gov
• STRUCTURAL STUDIES OF EBNA1 AND HOST TELOMERE PROTECTION PROTEINS AT THE EPSTEIN-BARR VIRUS ORIGIN OF LATENT REPLICATION#929158ScholarlyCommons
• Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review#211595ODU Digital Commons
• A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection#347949HAL (France)
• Additional file 1 of Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer#652507Figshare
• Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer#980327ClinicalTrials.gov
• The role of flow cytometric assessment of TRBC1/2 expression in ruling out hematologic malignancy in a patient with EBV/CMV induced lymphoproliferation: A case report#386526ARPHA OAI-PMH Endpoint
• Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.#807388ClinicalTrials.gov
• Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma#879581ClinicalTrials.gov
• Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugs#123282Europe PMC
• Multi-Center Registry for ME/CFS#828848ClinicalTrials.gov
• Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis#849820ClinicalTrials.gov
• Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies#835689ClinicalTrials.gov
• Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)#888357ClinicalTrials.gov